Skip to content

Archive for

Research – Supremex

Supremex

  • market cap of $31mm at $1.12
  • they have $100mm of net debt
  • in Q220 had earnings of 7c, EBITDA of $6.9mm, revenue of $47.7mm
  • revenue was flat yoy, envelope revenue was down 3.5%
  • net cash flow from ops was $10.7mm, up from $5mm yoy
  • they get $22mm of revenue from Canadian envelope segment, $10.6mm from US envelope segment
  • EBITDA was $14.6mm from H1 – so that is $30mm of EBITDA on a $130mm EV
  • leading manufacturer of envelopes and paper packaging
  • operate 13 facilities across 6 provinces in Canada, 3 facilities in US
  • manufactures stock and custom envelopes
  • corrugated boxes, folding carton packaging, e-comm fulfillment solutions
  • also these products: Conformer Products®1, polyethylene bags for courier applications, bubble mailers, Enviro-logiX®2and Tyvek®3and other related products such as RFID protective envelopes, X-ray envelopes, medical and file folders, repositionable notes, membership cards as well as labelling products
  • Q220 results
  • they have been developing new e-comm relationships
  • extracting synergies from Royal Envelope acquisition
  • they bought Royal Envelope for $27mm – had $30mm of revenue
  •                 margins roughly the same as SXP – from Q120 call
  • if I assume Royal had 15% EBITDA margins like SXP they would have bought it at 6x EBITDA – not exactly a steal if this is the case
  • they are planning to use Royal capacity to expand US business
  • said they can increase production 10-15% now without any more bodies
  • their envelope segment revenue is declining
  •                 down 4.7% yoy in Canada
  •                 down 1% yoy in US
  • revenue from packaging and specialty products has been up – 8.9% yoy
  • 54% of revenue came from packaging in Q220
  • I’m guessing that the stock tanked because of comments like this, though it seems like they’ve righted the ship and the stock is still down:

We announced with Q1 results that in April, we were experiencing a revenue decline of approximately 20% on the legacy business and 6%, including Royal Envelope. Fortunately, between the combination of continued onboarding of e-commerce wins and a general improvement in market conditions starting in mid-May and into June, we were able to finish the quarter at essentially flat for the corresponding quarter in 2019.

  • it lines up with the chart – stock was doing pretty well until May 14 when it tanked on earnings and then kept going
  • when you go back and look at last 10 years, it doesn’t really look like a melting icecube as a whole though the envelope side obviously is

  • they have been using acquisitions to grow/maintain the top line, so there’s that
  • even with the underlying envelope business shrinking, the fcf is still reasonably strong and this year’s FCF before WC is setting up to be $20mm+
  • EBITDA seems to have stabilized and it looks on track to be higher yoy even with the pnademic
  • so again, it may not be a growth business, but it isn’t a disaster and it generates a lot of cash
  • there has been a couple of insider buys around the current stock level – $1.27ish
  • I don’t really get why this stock is as cheap as it is TBH, the bad news from Q1 didn’t really come to pass but the stock never recovered from it
  • 1.5-2x 2020e FCF (I’m not including acquisition capex) seems a little low

I bought some of this one last week.  Not expecting the world but do think it can get back to $2.

Research – NatGas

I have been in natgas stocks since shortly after the COVID bottom.  I mentioned it here.  They did well, pulled back (and I sold/chickened out briefly) and then took off again.  I’m in a basket of names.  Below is a comparison I did this week.  Rafi Tahmazian made some good points, particularly about how overlooked the Montney is, in a BNN interview a couple weeks ago.  Pretty much sums it up for me.  Meanwhile some of these stocks seem cheap even after the run-up.

Valuation:

Costs (H1 results):

In addition to the usual suspects that I have already mentioned owning (PEY, AAV, PNE), I think Spartan Delta looks very reasonable, has good management, former BXE assets that I am familiar with and thus I like it a lot.  Nuvista is also interesting to me as more of a levered flyer on the Montney and the option that we get a full-fledged price recovery like what Rafi speculates.

Research – Broadwind Energy

I have decided to try out something new for the blog.  Instead of just doing my usual posts and company updates on a irregular basis, I am going to start posting what I am researching on a day to day basis.  Whatever name I have researched will be posted, likely in point form, as I am basically going to copy and paste my notes from the word document that I am already jotting them down in.  We’ll see how this goes.  Most of the stocks I will mention will not be one’s that I will buy.

Broadwind Energy

  • $58mm market cap at $3.44
  • $32.5mm of debt – they put total debt at $22mm in 10Q, not sure why
  • precision manufacturer – low margins
  • manufactures structures, equipment, components for clean tech
  • 72% of revenue comes from wind energy – provides steel towers and adapters to wind turbine manufacturers
  • have production in Manitowic Wisconsin and Abilene Texas – have combined capacity of 550 towers or 1,650 sections – 1,100 MW of power
  • gearing segment is gears and gear boxes for a bunch of different industries
  • also have industrial segment hat supplies combined cycle natgas turbine market
  • in 2019 they grew revenue 42% yoy
  • H1 revenue growth came from heavy fabrication
  • revenue was up pretty decent yoy – from $41mm to $55mm in Q220
  • it is low margin business with ~10% gross margins
  • 3c EPS in Q220, 9c EPS in H120
  • they had positive cash flow before WC – around $5mm in H120 – with capex of $900k that is FCF of $4mm in H120
  • but their own estimate of FCF was -$8.6mm for Q220 because of WC changes
  • their backlog was down quite a bit $112mm vs $144mm yoy and book to bill was 0.7
  • here is what they said about backlog being down:

We booked $39,558 in new orders in the second quarter of 2020, down from $104,612 in the second quarter of 2019 driven primarily by a $64,927 decrease in Heavy Fabrication orders as certain tower customers secured production capacity in the prior year in advance of historical lead times due to surging wind tower installation expectations in 2020.

  • saw weaker orders from mining and construction due to COVID
  • their Heavy Fab order yoy were down pretty significantly, from $96mm to $31mm
  • gearing segment down due to lack of orders from O&G
  • they did say they expect H220 to be similar to H120 so fcf should be strong in H220 – but then said they thought uncertainty from COVID would impact Q420 results
  • before COVID they did see strong orders – in Q419 they said orders in 2019 were double yoy and book to bill was 1.24 – backlog at YE was $142mm, up 80% yoy
  • honestly I don’t see why this stock is up so much, free cash seems decent and over the long run wind energy capacity grows but why the stock tripled from the bottom, I’m not sure, seems a little much, maybe why the price has peeled off

 

August Update – More Rotation

There was a tweet I saw earlier this week explaining that bloggers should reduce the size of their posts and clearly identify their themes with headlines to benefit their readers. Because of my concern about increasing my readership, I will do neither of these things.

With that said, this is a post about stocks, not theory, as the last few of my posts have been. So it will probably be more interesting on that alone. I will do my best to countervail that with long, drawn out text descriptions and no illustrations.

Well as they say on the True Crime Garage, that is enough of the business. On with the show. I am starting to roll my portfolio over into names that stand to benefit once things get back to normal.

I would not go so far as to buy an airline or a restaurant just yet.  But I have noticed a number of names that have produced very good results and that should continue to produce good results as the economy recovers.   And some of theses stocks seem unreasonably cheap.

The biggest of my purchases has been Big 5 Sporting Goods.  If you go back in my portfolio, you’ll note that I have owned BGFV before.  It was a position before the pandemic, and it was a position briefly in May, but I sold out too soon.

I was very close to buying it back leading up to their second quarter results but unfortunately I did not.  The results were extremely good, and the stock popped.  Not one to be deterred by a rising stock price, I bought the stock after that pop, as I think it should be able to carry on higher.

BGFV saw same-store-sales (SSS) increase by 15.5% in the second half of Q2, once their stores had begun to open.  In July this carried on to even higher heights – to 31.9% SSS growth.

Diluted earnings for the quarter were 52c per share.  Guidance for the third quarter was even better; BGFV estimated that it will come in between $1 and $1.30 per share.  In July the company eliminated all of its debt and has a cash position of $38 million against a market cap of $138 million.

Even as I type this, I feel compelled to add more.  The stock, which is trading a little over $6 right now (as an FYI I wrote this yesterday and now it is up even more I see), seems way too cheap given these results.

The second name I added was Waitr.  Mark Gomes did a video write-up on them on Youtube a few weeks ago.  Now I actually haven’t watched that video.  But I assume it is quite good. Still, I first came across the name when I received an email about the video being posted so I have to give the hat tip to him for the introduction.

As an aside, not watching the video was intentional.  I have kind of taken a different stance to tips of late.  I decided I do not want to know why other investors like an idea.  I love getting new names or symbols to look at, but I do not want to hear why I should buy it.

Why is this?  I have noticed a trend – many of the bad ideas I have been in over the last few years have come from other people’s rec’s.  I am not sure why I make poor choices on other people’s ideas, or what it is saying about me, but I decided on a resolution to not review anyone else’s blogs or reports or tweets on anything. 

I began to do this in March and to be honest, it is working out well. It may make for a lonely existence but I think it is necessary given my propensity to be talked into bad stocks by other people.

I will, however, take names and research them myself, which is what I did with Waitr.  It looks like a great idea to me.  They are a food delivery service, based in the southern states, they did an acquisition last year that seems to have went south itself, and left the company losing a ton of money, but then COVID came along and they blew the doors off with the first quarter results.

But this does not seem to be just a COVID story.  The first quarter results were good, but it was in large part because they got their costs aligned with their revenue and actually generated cash for the first time.

I took a small position in early July, but I backed up the truck yesterday when the stock inexplicably dropped a buck after announcing their second quarter earnings.

From what I can tell, the second quarter was even better than the first.  If I look at free cash flow before working capital changes it came in at over $15 million.  At $4.50 this is a company with a market cap of $360 million.  They also got back on the year-over-year growth train in Q2 – growing the top line at 17.8%.   It just does not make any sense to me that the stock should fall on these results.  So, I added a bunch.

Another name I added on a dip is an old favorite – Smith Micro.  Smith did not put together a great second quarter and the stock dropped below $4 yesterday as a result.  But when I read through the conference call transcript it sure sounded to me like they have a bunch of new carrier wins that are on the verge of being signed.  On the call they described it as “late-stage” and “contract” negotiations, which kind of imply to me it is just a matter of dotting I’s and crossing t’s.

I also bought back small amounts of a couple of other positions I previously held – Evolent Health and Sharps Compliance.

Evolent had a really good second quarter, much better than I thought they could have.  They finally showed a decent growth number and are now EBITDA positive. The Passport debacle did not turn out well (count me as surprised that the new Kentucky administration still passed on Passport when they re-evaluated the awards).  But Evolent appears to be getting their money back and maybe more from the sale of Passport’s customers to Molina and the return of statuatory capital. They have also made inroads with one of the winners of the Kentucky program awards, Molina, which they have said will be partnering with Evolent in two states, Kentucky and Oregon. Evolent used to be a $20+ stock. I have always thought it could get back there if they got their shit together, and maybe they finally have.

Sharps Compliance is really the same story it was a few months ago.  They should benefit from the eventual vaccine deployment.  The stock came back into the $6’s and I thought it was worth buying there.  Now it is back in the $8’s and I am less excited about it here.

I am looking closely at another previously held name – DLH Holdings.  They also had a very good second quarter and the company is generating a lot of free cash.  I also added a small position on a second economic recovery name, the At Home Group, but this is another stock I have to dig into more before I can say with certainty that I am onboard.

The other more interesting situation that I am looking into right now is the BankMobile merger with Megalith Financial Acquisition Group.  I have talked about MFAC in the comments a few months ago and have held a tiny position in the stock for a while.

On Thursday MFAC announced what I suspected was going to happen – that they bought and were going to take public BankMobile from Customers Bancorp.

While BankMobile is interesting, it is CUBI that has caught my eye right now.  The bank is trading at under 50% of tangible book.  The second quarter earnings were out and they were not that bad.  CUBI has done the same thing as another bank I own (Sound Financial) – generated a lot of PPP loans – in fact CUBI is the 6th biggest PPP lender in the country.

BankMobile is a nice growth business but it was not doing much for CUBI.  In fact, BankMobile lost $12 million before taxes last year according to the disclosures released yesterday, which means that they were a drag on pre-tax earnings by about 15%.

CUBI will take equity in BankMobile as part of the transaction, so they will still benefit from growth of that business.  And just taking a step back, I think you have to take BankMobile out of CUBI so that it can expand the deposit generation franchise to other banks. The whole point with BankMobile seems to be to collect fees from the deposits they generate. Having more banks onboard just increases their reach. There is also an issue with CUBI’s size, as they have limits on the fees they can charge to merchants from BankMobile transactions once CUBI gets too big (it is something called the Durban amendment). Making BankMobile its own entity eliminates this growth constraint on CUBI.

The dig on both CUBI and the transaction is that it is an example of both nepotism and cronyism.  It is hard to disagree with this. Jay Sidhu, the CEO of CUBI, also runs MFAC, the SPAC that bought BankMobile, and his daughter is the CEO of BankMobile and will be the CEO of the new company.

I admit that does not look good.  Sidhu is also benefiting through his founder shares, (though he is forfeiting most of them, there are still around 800,000 that he plans to keep, which he got basically for free, and so this is a pretty good payday for him).  But the deal also does not seem particularly unfair to either side to me, at least based on what I have been able to see so far. But I have to say, I am still trying to figure it all out and the disclosures are painful to read through. My bottom line opinion right now is that at such a low price to book I am inclined to take a chance on CUBI.

That wraps up all the buys.  My sells are pretty simple. I have sold pretty much all the SaaS stocks I owned other than PagerDuty and I have been lightening up on my gold stocks after this tremendous run. I also sold the rest of Overstock (too soon of course).

That is pretty much it for now.  Good luck!